Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021

Abstract Background Human T-cell Lymphotropic Virus type-1 (HTLV-1) infection is associated with serious disorders, including Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). In addition to sexual, vertical, parenteral, and blood transfus...

Full description

Saved in:
Bibliographic Details
Main Authors: Arash Letafati, Sayed Hamidreza Mozhgani, Mehdi Norouzi, Amir Aboofazeli, Zahra Taghiabadi, Negar Zafarian, Saba Seyedi, Elnaz Mohammad Jaberi, Sedigheh Poursaleh, Maryam Karami, Sheida Sarrafzadeh, Ahmadreza Sadeghi
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Retrovirology
Subjects:
Online Access:https://doi.org/10.1186/s12977-024-00656-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850254068089356288
author Arash Letafati
Sayed Hamidreza Mozhgani
Mehdi Norouzi
Amir Aboofazeli
Zahra Taghiabadi
Negar Zafarian
Saba Seyedi
Elnaz Mohammad Jaberi
Sedigheh Poursaleh
Maryam Karami
Sheida Sarrafzadeh
Ahmadreza Sadeghi
author_facet Arash Letafati
Sayed Hamidreza Mozhgani
Mehdi Norouzi
Amir Aboofazeli
Zahra Taghiabadi
Negar Zafarian
Saba Seyedi
Elnaz Mohammad Jaberi
Sedigheh Poursaleh
Maryam Karami
Sheida Sarrafzadeh
Ahmadreza Sadeghi
author_sort Arash Letafati
collection DOAJ
description Abstract Background Human T-cell Lymphotropic Virus type-1 (HTLV-1) infection is associated with serious disorders, including Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). In addition to sexual, vertical, parenteral, and blood transfusion, organ/tissue transplantation is considered as a transmission route of HTLV infection. Given the substantial risk of HTLV-1 transmission and the subsequent development of HAM/TSP (approximately 40%) in kidney transplant recipients, pre-transplant donor screening is crucial. The present study aimed to investigate the prevalence of HTLV-1 in potential organ/tissue donors referred to the Iranian Tissue Bank and Research Center (ITBRC). Materials and methods The study population was potential organ and/or tissue donors referred to ITBRC between 2014 and 2021, including two groups of brain death (potential donors of organs and/or tissues) and circulatory death donors (potential tissue donors from Iranian Legal Medicine Organization). Initial screening was performed using enzyme-linked immunosorbent assay (ELISA), and positive cases were confirmed for HTLV-1 infection with polymerase chain reaction (PCR). Results 111 out of 3,814 donors were positive for HTLV-1 (3%). The rate of positive tests between 2014 and 2017 was 6%, which was significantly higher than the positive tests percentage between 2017 and 2021 with 0.5% (P-value < 0.001). The rate of test positivity in females was 4% compared to 2% in males (P-value = 0.001). Furthermore, individuals diagnosed with brain death exhibited a significantly lower likelihood of HTLV-1 infection (0.2%) compared to cases with circulatory death (4%) (P-value < 0.001). Conclusion Considering the contraindication of organ/tissue donation from donors with HTLV-1 positive test, these findings give an insight into the prevalence of HTLV-1 among potential organ/tissue donors in Iran. Moreover, the higher prevalence of HTLV-1 infection in circulatory death donors from Iranian Legal Medicine Organization urges for cautious evaluation in these donors.
format Article
id doaj-art-93ac76e4aab64d73be0348a24ec0c0f4
institution OA Journals
issn 1742-4690
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Retrovirology
spelling doaj-art-93ac76e4aab64d73be0348a24ec0c0f42025-08-20T01:57:12ZengBMCRetrovirology1742-46902024-12-012111510.1186/s12977-024-00656-9Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021Arash Letafati0Sayed Hamidreza Mozhgani1Mehdi Norouzi2Amir Aboofazeli3Zahra Taghiabadi4Negar Zafarian5Saba Seyedi6Elnaz Mohammad Jaberi7Sedigheh Poursaleh8Maryam Karami9Sheida Sarrafzadeh10Ahmadreza Sadeghi11Department of Virology, School of Public Health, Tehran University of Medical SciencesDepartment of Microbiology and Virology, School of Public Health, Alborz University of Medical SciencesDepartment of Virology, School of Public Health, Tehran University of Medical SciencesResearch Center for Clinical Virology, Tehran University of Medical ScienceResearch Center for Clinical Virology, Tehran University of Medical ScienceResearch Center for Clinical Virology, Tehran University of Medical ScienceResearch Center for Clinical Virology, Tehran University of Medical ScienceResearch Center for Clinical Virology, Tehran University of Medical ScienceIranian Tissue Bank and Research Center, Tehran University of Medical SciencesIranian Tissue Bank and Research Center, Tehran University of Medical SciencesResearch Center for Clinical Virology, Tehran University of Medical ScienceIranian Tissue Bank and Research Center, Tehran University of Medical SciencesAbstract Background Human T-cell Lymphotropic Virus type-1 (HTLV-1) infection is associated with serious disorders, including Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). In addition to sexual, vertical, parenteral, and blood transfusion, organ/tissue transplantation is considered as a transmission route of HTLV infection. Given the substantial risk of HTLV-1 transmission and the subsequent development of HAM/TSP (approximately 40%) in kidney transplant recipients, pre-transplant donor screening is crucial. The present study aimed to investigate the prevalence of HTLV-1 in potential organ/tissue donors referred to the Iranian Tissue Bank and Research Center (ITBRC). Materials and methods The study population was potential organ and/or tissue donors referred to ITBRC between 2014 and 2021, including two groups of brain death (potential donors of organs and/or tissues) and circulatory death donors (potential tissue donors from Iranian Legal Medicine Organization). Initial screening was performed using enzyme-linked immunosorbent assay (ELISA), and positive cases were confirmed for HTLV-1 infection with polymerase chain reaction (PCR). Results 111 out of 3,814 donors were positive for HTLV-1 (3%). The rate of positive tests between 2014 and 2017 was 6%, which was significantly higher than the positive tests percentage between 2017 and 2021 with 0.5% (P-value < 0.001). The rate of test positivity in females was 4% compared to 2% in males (P-value = 0.001). Furthermore, individuals diagnosed with brain death exhibited a significantly lower likelihood of HTLV-1 infection (0.2%) compared to cases with circulatory death (4%) (P-value < 0.001). Conclusion Considering the contraindication of organ/tissue donation from donors with HTLV-1 positive test, these findings give an insight into the prevalence of HTLV-1 among potential organ/tissue donors in Iran. Moreover, the higher prevalence of HTLV-1 infection in circulatory death donors from Iranian Legal Medicine Organization urges for cautious evaluation in these donors.https://doi.org/10.1186/s12977-024-00656-9Organ transplantationHTLV-1TissueBrain deathCirculatory death
spellingShingle Arash Letafati
Sayed Hamidreza Mozhgani
Mehdi Norouzi
Amir Aboofazeli
Zahra Taghiabadi
Negar Zafarian
Saba Seyedi
Elnaz Mohammad Jaberi
Sedigheh Poursaleh
Maryam Karami
Sheida Sarrafzadeh
Ahmadreza Sadeghi
Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
Retrovirology
Organ transplantation
HTLV-1
Tissue
Brain death
Circulatory death
title Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
title_full Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
title_fullStr Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
title_full_unstemmed Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
title_short Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021
title_sort declining trend of htlv 1 among organ tissue donors in iranian tissue bank between 2014 2021
topic Organ transplantation
HTLV-1
Tissue
Brain death
Circulatory death
url https://doi.org/10.1186/s12977-024-00656-9
work_keys_str_mv AT arashletafati decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT sayedhamidrezamozhgani decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT mehdinorouzi decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT amiraboofazeli decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT zahrataghiabadi decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT negarzafarian decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT sabaseyedi decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT elnazmohammadjaberi decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT sedighehpoursaleh decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT maryamkarami decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT sheidasarrafzadeh decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021
AT ahmadrezasadeghi decliningtrendofhtlv1amongorgantissuedonorsiniraniantissuebankbetween20142021